A Phase I, Open-lable, Randomized, Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Different Antihyperglycemic Drugs in the Treatment of Pasireotide-associated Hyperglycemia.

Trial Profile

A Phase I, Open-lable, Randomized, Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Different Antihyperglycemic Drugs in the Treatment of Pasireotide-associated Hyperglycemia.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Dec 2015

At a glance

  • Drugs Liraglutide (Primary) ; Metformin (Primary) ; Nateglinide (Primary) ; Pasireotide (Primary) ; Vildagliptin (Primary)
  • Indications Acromegaly; Gastrointestinal cancer; Gastrointestinal disorders; Gigantism; Liver cancer; Malignant melanoma; Meningioma; Merkel cell carcinoma; Neuroendocrine tumours; Obesity; Pancreatic cancer; Pancreatic disorders; Pituitary cancer; Prostate cancer; Type 1 diabetes mellitus; Type 2 diabetes mellitus; Uveal melanoma
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 01 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top